ERNAW ERNEXA THERAPEUTICS INC
Follow*W EXP 02/04/203 (warrant or right), issuer CIK 748592
Filings received so far for Q3 2026: 7 13F filers report a position in ERNAW shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Bleichroeder LPin group Bleichroeder LP | 2,000,000 | $63.4K | 0.01% | 0 | 13F-HRTimelineGroup |
| HEIGHTS CAPITAL MANAGEMENT, INCin group HEIGHTS CAPITAL MANAGEMENT, I… | 400,000 | $14K | <0.01% | 0 | 13F-HRTimelineGroup |
| SUSQUEHANNA INTERNATIONAL GROUP, LLPin group SUSQUEHANNA INTERNATIONAL GRO… | 158,456 | $5.55K | <0.01% | +100,566 | 13F-HRTimelineGroup |
| ARMISTICE CAPITAL, LLCin group ARMISTICE CAPITAL, LLC | 160,000 | $5.07K | <0.01% | 0 | 13F-HRTimelineGroup |
| Clear Street Group Inc.in group Clear Street Group Inc. | 150,679 | $4.78K | <0.01% | +1,180 | 13F-HRTimelineGroup |
| Warberg Asset Management LLC | 60,359 | $1.91K | <0.01% | -9,071 | 13F-HRTimeline |
| HRT FINANCIAL LP | 22,346 | $0 | 0% | new | 13F-HRTimelineValue filed as zero, left out of ratios. |